LUCD News and Press, Lucid Diagnostics Inc. From 11/20/25

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire Recognized as the leading company in its size category in program honoring the top workplaces across the diagnostics and precision-medicine sectors NEW YORK , Nov. 20, 2025 /PRNe...

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire NEW YORK , Nov. 13, 2025 ...

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire Veris Health launched commercial phase of strategic partnership and relaunched development of implantable physiological monitor PAVmed signed letter of intent (LOI) to license ground...

2025-11-12 14:42:28 ET More on Lucid Diagnostics Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript Lucid Diagnostics: Holding Onto Medicare Coverage Hopes Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript) Lucid Diagnostics dips ...

2025-11-12 14:41:38 ET Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST... Read the full article on Seeking Alpha For further details see: Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript

2025-11-12 13:32:02 ET More on Lucid Diagnostics Lucid Diagnostics: Holding Onto Medicare Coverage Hopes Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript) Lucid Diagnostics dips after pricing $25M stock offering Lucid Diagnostics announces p...

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire Processed 2,841 EsoGuard ® tests and recognized 3Q25 revenue of $1.2 million , ending quarter with over $47 million in proforma cash and extending runway through 2026 an...

RWE AG ADR (RWEOY) is expected to report $0.16 for Q3 2025 Hillenbrand Inc (HI) is expected to report $0.62 for Q4 2025 Ardent Health Inc. (ARDT) is expected to report $0.42 for Q3 2025 Quince Therapeutics Inc. (QNCX) is expected to report $-0.2 for Q3 2025 GlobalFoundries Inc. (G...

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK , Oct. 29, 2025 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or t...

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK , Oct. 15, 2025 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and s...